Establishing an Anti-Müllerian hormone cutoff for diagnosis of polycystic ovarian syndrome in women of reproductive age-bearing Indian ethnicity using the automated Anti-Müllerian hormone assay
Context: Polycystic ovary syndrome diagnosed by Rotterdam criteria, is the most common cause of anovulatory infertility. The criteria of polycystic ovarian morphology (PCOM) are subject to operator variability and technological advances. Serum anti-Müllerian hormone (AMH) level has been proposed as...
Main Authors: | Nalini Mahajan, Jasneet Kaur |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Journal of Human Reproductive Sciences |
Subjects: | |
Online Access: | http://www.jhrsonline.org/article.asp?issn=0974-1208;year=2019;volume=12;issue=2;spage=104;epage=113;aulast=Mahajan |
Similar Items
-
Clinical Utilities of Anti-Müllerian Hormone
by: Nicole Russell, et al.
Published: (2022-12-01) -
Role of anti-Mullerian hormone in polycystic ovary syndrome
by: Koushik Bhattacharya, et al.
Published: (2022-10-01) -
Serum anti-Müllerian hormone as a predictor of polycystic ovarian syndrome among women of reproductive age
by: Muhammad Salman Butt, et al.
Published: (2022-05-01) -
Diagnostic Accuracy of Anti-Mullerian Hormone for Polycystic Ovary Syndrome
by: Kulsoom Bahadur, et al.
Published: (2023-04-01) -
Correlation of Anti-Müllerian Hormone with Polycystic Ovarian Disease and its Relation with Age
by: Sara Omer Muhammed, et al.
Published: (2019-08-01)